Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) can preserve the stability of TFRC mRNA through m6A modifications, thereby increasing TFRC protein levels in colorectal cancer (CRC) cells and facilitating the growth of CRC [64]. This evidence concerns the gene TFRC and colorectal carcinoma.